As predicted, the GLP-1 revolution has only accelerated, and this miracle drug will reshape the orthopedic landscape going forward.
Recent data reveals that GLP-1 adoption in the U.S. has exceeded expectations, with roughly 15% of the population having tried these drugs and 10% using them consistently—numbers that echo last year’s bold demand forecasts—while 50% of Americans express interest in starting them.
Beyond their well-known weight loss effects, studies emerging this month position GLP-1s as potential healthcare game-changers, showing promise in reducing orthopedic surgery rates, add...
